Dr. Reddy's expected to post Q4 net profit of ₹1,040cr
NewsBytes | May 11, 2026 11:39 PM CST
Dr. Reddy's reports results May 12
The company will share its Q4 and full-year results on May 12.
Despite tough times in the US market and rising freight expenses, Dr. Reddy's is still pushing forward.
Just this March, they launched Obeda, India's first generic semaglutide for type 2 diabetes after getting the green light from DCGI.
READ NEXT
-
Cooler Smell: If there is a smell coming from the air of the cooler? So do this, the fragrance will spread
-
Health effects of sleeping in AC in summer
-
Ban on transfers will be lifted soon, proposal for new transfer policy will come in the next Mohan cabinet meeting! draft ready
-
Are you troubled by stomach upset and constipation? Gastroenterologist told these 5 magical drinks
-
Woman in China fined for dancing and applying makeup while driving
